# Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults

> **NCT02704091** · PHASE4 · COMPLETED · sponsor: **Ipsen** · enrollment: 858 (actual)

## Conditions studied

- Acute Diarrhoea

## Interventions

- **DRUG:** Smecta
- **DRUG:** Smecta placebo

## Key facts

- **NCT ID:** NCT02704091
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-17
- **Primary completion:** 2019-04-08
- **Final completion:** 2019-04-08
- **Target enrollment:** 858 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02704091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02704091, "Efficacy of Diosmectite (Smecta®) in the Symptomatic Treatment of Acute Diarrhoea in Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02704091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*